COHERUS ONCOLOGY INC. - COMMON STOCK

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

07 8月 2025 13:41:26 条件 Nasdaq GlobeNewswire

Coherus Oncology to Report Second Quarter 2025 Financial Results on August 7, 2025

31 7月 2025 13:45:17 条件 Nasdaq GlobeNewswire

Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics

30 5月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)

27 5月 2025 05:30:00 条件 Nasdaq GlobeNewswire

Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update

12 5月 2025 13:15:13 条件 Nasdaq GlobeNewswire

Coherus to Report First Quarter 2025 Financial Results on May 12, 2025

05 5月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Coherus to Participate in Upcoming Investor Conferences

01 5月 2025 14:04:28 条件 Nasdaq GlobeNewswire

Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025

28 4月 2025 07:10:11 条件 Nasdaq GlobeNewswire

Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise

14 4月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes

01 4月 2025 05:00:54 条件 Nasdaq GlobeNewswire

Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual Meeting

25 3月 2025 13:30:00 条件 Nasdaq GlobeNewswire

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update

10 3月 2025 13:12:56 条件 Nasdaq GlobeNewswire

Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025

03 3月 2025 05:30:00 条件 Nasdaq GlobeNewswire

Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference

24 2月 2025 06:08:12 条件 Nasdaq GlobeNewswire

Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025

22 1月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08 1月 2025 05:00:00 条件 Nasdaq GlobeNewswire

Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025

18 12月 2024 05:30:00 条件 Nasdaq GlobeNewswire

Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.

03 12月 2024 04:00:00 条件 Nasdaq GlobeNewswire

Coherus Management to Participate in the 2024 Citi Global Healthcare Conference

27 11月 2024 13:01:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

05 11月 2024 06:45:06 条件 NetDania Notify